Department of Pediatrics, Yale University School of Medicine, New Haven, CT, USA.
Institute of Diabetes, Endocrinology and Metabolism, Rambam Health Care Campus, PO Box 9602, 3109601, Haifa, Israel.
Adv Ther. 2023 Nov;40(11):4711-4720. doi: 10.1007/s12325-023-02642-7. Epub 2023 Sep 5.
Type 2 diabetes (T2D) in youth is a global health concern characterized by an increasing incidence and prevalence, especially among disadvantaged socioeconomic subgroups. Moreover, youth-onset T2D is more aggressive and causes earlier, more severe long-term cardio-renal complications compared with T2D in adults. The therapeutic options available are limited and often inadequate, partially due to the numerous challenges in implementing clinical trials for this vulnerable patient population. Over the last few years, a significant effort has been made to develop new effective drugs for children and adolescents with T2D. Specifically, a number of studies are currently generating new data to address the urgent unmet medical need for optimal management of this disease. This review describes the central features of youth-onset T2D and summarizes the available treatments and ongoing studies in pediatric patients.
2 型糖尿病(T2D)在年轻人中是一个全球性的健康问题,其发病率和患病率呈上升趋势,尤其是在社会经济地位处于不利地位的亚组中。此外,与成年人的 T2D 相比,青年发病的 T2D 更为严重,且导致更早、更严重的长期心肾并发症。现有的治疗选择有限,且往往不够充分,部分原因是在实施针对这一弱势群体的临床试验方面存在诸多挑战。在过去几年中,人们为开发治疗儿童和青少年 T2D 的新型有效药物付出了巨大努力。具体来说,目前有多项研究正在产生新的数据,以满足这一疾病的最佳管理方面的迫切未满足的医疗需求。本综述描述了青年发病 T2D 的主要特征,并总结了儿科患者的现有治疗方法和正在进行的研究。